Rebecca Haydock, Helen Rollins, Harriet E Wallace, T. Hepburn, J. Ross, J. Wilson
{"title":"P006在全球大流行期间招募随机对照试验(RCT):对DEVA试验进行调整,以便在封锁期间及以后招募患者","authors":"Rebecca Haydock, Helen Rollins, Harriet E Wallace, T. Hepburn, J. Ross, J. Wilson","doi":"10.1136/sextrans-bashh-2023.47","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":20305,"journal":{"name":"Posters","volume":"15 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P006 Recruiting to a randomised-controlled trial (RCT) during a global pandemic: adaptations made to the DEVA trial to recruit patients through lockdown and beyond\",\"authors\":\"Rebecca Haydock, Helen Rollins, Harriet E Wallace, T. Hepburn, J. Ross, J. Wilson\",\"doi\":\"10.1136/sextrans-bashh-2023.47\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":20305,\"journal\":{\"name\":\"Posters\",\"volume\":\"15 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Posters\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1136/sextrans-bashh-2023.47\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Posters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/sextrans-bashh-2023.47","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
P006 Recruiting to a randomised-controlled trial (RCT) during a global pandemic: adaptations made to the DEVA trial to recruit patients through lockdown and beyond